Clarus Therapeutics
Northbrook
About Clarus Therapeutics
Clarus Therapeutics is a biopharmaceutical company that develops androgen-based medicines for men and women. It offers OriTex, a proprietary oral testosterone product for use in men with low testosterone levels.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 11 – 50
- Estimated revenue: $10K – $50K
- Total funding: $122.0M
- Funding stage: IPO
- Last round: Post-IPO Equity (Apr 2022)
- Ticker: nasdaq:CRXT
- Website: clarustherapeutics.com
- Phone: 847-562-4300
Industries & Categories
Biotechnology, Health Care, Life Science, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/clarus-therapeutics-79160 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.